Rebif Compliance Support Program - Assessing Needs in Multiple Sclerosis

Clinical trial NCT01080573 · COMPLETED

Trial details

NCT number: NCT01080573
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis

Start date: 2007-01-01
Primary completion: 2011-04-01
Enrollment: 1257

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.